Literature DB >> 11793487

Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population.

Zalman M Kahn1, Mukesh Kumar, Gerald Hollander, Robert Frankel.   

Abstract

Arterial puncture sites after cardiac catheterization are a troublesome cause of complications. Closure devices have been developed to improve on patient comfort and safety. We evaluated a suture-mediated closure device, the Prostar-Plus device, in a consecutive population of over 10,001 diagnostic and interventional catheterizations. A significantly higher complication rate was noted for both major and minor complications in the diagnostic catheterization patients treated with the Prostar-Plus device compared to diagnostic catheterization patients treated with manual compression (2.6% major and 4.6% minor complication rate for the Prostar-Plus treatment group vs. 0.2% major and 1.8% minor complication rate for the manual compression treatment group). For the interventional patients, there were no statistical differences noted for both major and minor complications between patients treated with the Prostar-Plus device vs. manual compression. Subgroup analysis showed that older, thinner women were more likely to have complications related to the Prostar-Plus device. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793487     DOI: 10.1002/ccd.10045

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

Review 1.  Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review.

Authors:  Kamran Khaghany; Firas Al-Ali; Thomas Spigelmoyer; Ron Pimentel; Kurt Wharton
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Successful use of the Cardiva Boomerang™ vascular closure device to close a brachial artery puncture site after emergency PTCA.

Authors:  Plinio Cirillo; Gianluca Petrillo; Greta Luana D'Ascoli; Federico Piscione; Massimo Chiariello
Journal:  Heart Vessels       Date:  2010-09-28       Impact factor: 2.037

Review 3.  Anticoagulation During AF Ablation: The Balance between Thromboembolism and Bleeding.

Authors:  Jennifer A Mears; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2009-02-01

4.  Safety and efficacy of the Perclose suture-mediated closure device following carotid artery stenting under clopidogrel platelet blockade.

Authors:  Niels Zorger; Thomas Finkenzeller; Markus Lenhart; Okka Hamer; Christian Paetzel; Inghita Borisch; Ingolf Toepel; Stefan Feuerbach; Johann Link
Journal:  Eur Radiol       Date:  2003-11-11       Impact factor: 5.315

5.  Vascular closure device failure: frequency and implications: a propensity-matched analysis.

Authors:  Sripal Bangalore; Nipun Arora; Frederic S Resnic
Journal:  Circ Cardiovasc Interv       Date:  2009-10-27       Impact factor: 6.546

6.  Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures.

Authors:  Ha Young Kim; Sung Wook Choo; Hong Gee Roh; Heon Han; Sam Soo Kim; Ji Yeon Lee; Yul Ri Park; Sung Hoon Lee; Sung Wook Shin; Kwang Bo Park; Young Soo Do; Sung Ki Cho; In Ho Lee; Sung Mok Kim; Hong Sik Byun; Pyoung Jeon
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.